Details of the Drug

General Information of Drug (ID: DM98NZR)

Drug Name
ATYR1923
Synonyms Efzofitimod
Indication
Disease Entry ICD 11 Status REF
Pulmonary sarcoidosis 4B20.0 Phase 3 [1]
Drug Type
Fusion protein
Cross-matching ID
TTD ID
DN2W9I

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neuropilin-2 (NRP2) TTRXUVC NRP2_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05415137) A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis. U.S.National Institutes of Health.
2 Efzofitimod for the Treatment of Pulmonary Sarcoidosis. Chest. 2023 Apr;163(4):881-890.